Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 26
Page 26 of 113 · 1018 articles
TPE Versus UPIC Review: Telling Education From Investigation
A Targeted Probe and Educate letter corrects billing error. A UPIC audit investigates fraud, and either can lead to the other.
UPIC Audits of Podiatry Practices: Routine Foot Care and Nail Care
How UPIC and MAC reviewers test podiatry claims for routine foot care and nail debridement, and what charts need to show.
The MATE Act Training Requirement for DEA Registrants
DEA registration applicants and renewing registrants must attest to MATE Act training. Who must attest, what qualifies, and what i…
What a DEA Surrender or Revocation Does to Your Medical License
A DEA surrender or revocation ends federal registration only. State license, hospital, payer, and Medicare consequences follow sep…
Medicare Self-Audits: Scope, Privilege, and Handling the Findings
How a physician practice should scope a Medicare self-audit, why privilege is not automatic, and what the overpayment rule require…
Owning Both a 503A Pharmacy and a 503B Outsourcing Facility
What FDA's guidance says, and does not say, about sharing an address, separating records, moving product, and interstate distribut…
Limited Distribution Drugs and Pharmacy Access
Manufacturers, not regulators, decide which pharmacies may dispense a limited distribution drug, and exclusion carries real audit…
Privilege Logs and Clawback Agreements in a DOJ Production
How healthcare providers identify privileged material, build a privilege log DOJ will accept, and negotiate a clawback agreement b…
Novitas Solutions Medicare Audits: TPE, Prepayment Review and Appeals
Novitas Solutions is the Medicare contractor for two jurisdictions. How its TPE reviews, documentation requests, and appeals actua…